Recurrent Squamous Cell Carcinoma of the Nasopharynx

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB152432-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a1Completed1
DB019337-Hydroxystaurosporine1Completed1
DB00062Albumin human1Active Not Recruiting1
DB12442Alvespimycin1Completed1
DB00112Bevacizumab1Completed1
DB00958Carboplatin1Active Not Recruiting1
DB00958Carboplatin1Completed1
DB00958Carboplatin1Terminated1
DB00002Cetuximab1Completed3
DB00002Cetuximab1Terminated1
DB00515Cisplatin1Completed1
DB00515Cisplatin1Withdrawn1
DB01248Docetaxel1Completed1
DB15631Edodekin alfa1Completed1
DB12304Entolimod1Withdrawn1
DB00530Erlotinib1Completed2
DB01590Everolimus1Completed1
DB00099Filgrastim1Completed1
DB00544Fluorouracil1Active Not Recruiting1
DB00544Fluorouracil1Completed1
DB01005Hydroxyurea1Active Not Recruiting1
DB01005Hydroxyurea1Completed1
DB00762Irinotecan1Completed1
DB16555Lactoferrin1Terminated1
DB12303Motolimod1Completed1
DB15721Natural Killer Cell1Completed1
DB01229Paclitaxel1Active Not Recruiting1
DB01229Paclitaxel1Completed1
DB01229Paclitaxel1Terminated1
DB00398Sorafenib1Completed1
DB01268Sunitinib1Terminated1
DB00072Trastuzumab1Completed1
DB02546Vorinostat1Terminated1
DB00112Bevacizumab1 / 2Completed2
DB11666Buparlisib1 / 2Completed1
DB00002Cetuximab1 / 2Completed2
DB01248Docetaxel1 / 2Completed1
DB00530Erlotinib1 / 2Completed4
DB06151Acetylcysteine2Completed1
DB00112Bevacizumab2Completed1
DB14235Bilberry2Withdrawn1
DB00188Bortezomib2Completed1
DB16741Bortezomib D-mannitol2Completed1
DB00958Carboplatin2Completed1
DB00002Cetuximab2Completed2
DB01254Dasatinib2Completed1
DB14240Echinacea2Withdrawn1
DB00530Erlotinib2Completed1
DB00762Irinotecan2Completed1
DB01259Lapatinib2Completed2
DB01229Paclitaxel2Completed1
DB06589Pazopanib2Completed1
DB11805Saracatinib2Completed1
DB00398Sorafenib2Completed2
DB01268Sunitinib2Completed1
DB00317GefitinibNot AvailableCompleted1